The Food and Drug Administration (FDA) has launched an investigation into whether the yeast infection treatment fluconazole (Diflucan) increases the risk of miscarriage in pregnant women. The safety label currently on the anti-fungal medication states that available data from studies does not suggest an increased risk of pregnancy complications or abnormalities in developing fetuses when women were given a single 150 mg dose of oral fluconazole to treat vaginal yeast infections. However, high doses of oral fluconazole (400-800 mg/day) taken by pregnant women for much longer than a single dose have resulted in reports of abnormalities at birth. A recent ... Read More
Righting Injustice is published by the Beasley Allen Law Firm. If you are interested in a free legal consultation, please take a few moments to fill out the contact form with as many details as possible. The more information you provide us, the better we can evaluate your claim.